Immuron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.About IMRN
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.
CEOSteven Lydeamore
CEOSteven Lydeamore
Employees—
Employees—
HeadquartersBlackburn, Victoria (VIC)
HeadquartersBlackburn, Victoria (VIC)
Founded1994
Founded1994
Employees—
Employees—
IMRN Key Statistics
Market cap11.21M
Market cap11.21M
Price-Earnings ratio-2.51
Price-Earnings ratio-2.51
Dividend yield—
Dividend yield—
Average volume2.41M
Average volume2.41M
High today$1.47
High today$1.47
Low today$1.45
Low today$1.45
Open price$1.53
Open price$1.53
Volume11.33K
Volume11.33K
52 Week high$2.48
52 Week high$2.48
52 Week low$1.42
52 Week low$1.42
Stock Snapshot
With a market cap of 11.21M, Immuron(IMRN) trades at $1.46. The stock has a price-to-earnings ratio of -2.51.
As of 2025-12-09, Immuron(IMRN) stock has fluctuated between $1.45 and $1.47. The current price stands at $1.46, placing the stock +0.6% above today's low and -0.7% off the high.
Immuron(IMRN) shares are trading with a volume of 11.33K, against a daily average of 2.41M.
In the last year, Immuron(IMRN) shares hit a 52-week high of $2.48 and a 52-week low of $1.42.
In the last year, Immuron(IMRN) shares hit a 52-week high of $2.48 and a 52-week low of $1.42.
IMRN News
TipRanks 5d
Immuron Limited Announces Proposed Securities IssueTipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...